GreenLight Biosciences
GRNA
GreenLight Biosciences (GRNA) - Cash on Hand
Cash on Hand as of March 2023 : $32.35 M
According to GreenLight Biosciences's latest financial reports the company has $32.35 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GreenLight Biosciences - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $68.09 M | 116.55% |
| 2021-12-31 | $31.44 M | -66.92% |
| 2020-12-31 | $95.06 M | 266.83% |
| 2019-12-31 | $25.91 M |